Mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) and its mitochondrial homolog isocitrate dehydrogenase 2 (IDH2) are far less common in CH than in AML, collectively representing <1% of mutations [4,54]. Here, IDH1 is linked to cyclic hematopoiesis.